지노믹트리

228760KOSDAQ자연과학 및 공학 연구개발업

58.8 / 100

Reference Date: 2026-06-10

Financial Score24.5 / 40

News Sentiment21.3 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 25.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

GenomicTree is a South Korean company specializing in early cancer detection using biomarker-based molecular diagnostics, with its flagship product 'EarlyTect-Colon Cancer' approved in 2018. The test uses stool DNA and offers high sensitivity and rapid results, competing with traditional colonoscopies. The company is expanding globally through subsidiaries in the U.S. and a joint venture in China, though 2024 revenue declined due to the end of its coronavirus diagnostic business.

Number of Employees

76people

Average Salary

51.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 62.704.0Point

PBR

2.54Industry Average 3.244.0Point

In line with industry avg

ROE

-7.62Industry Average -32.093.5Point

Well below industry avg

Debt Ratio

0.87Industry Average 7.318.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲14.1% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲18.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -7.9% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Positive
지노믹트리, 중추신경계 전달용 LNP 특허 출원
지노믹트리의 CNS 전달용 LNP 특허 출원으로 신약 개발 가능성이 높아져 긍정적인 시장 반응 예상.
Positive
지노믹트리, 美비뇨의학회서 방광암·전립선암 소변 진단 성과 공개
지노믹트리의 방광암 및 전립선암 비침습 분자진단 기술 임상 결과 발표로 인해 긍정적인 시장 반응 예상.
Positive
지노믹트리, ‘mRNA 발현 플랫폼’ 호주 특허 등록결정
지노믹트리의 mRNA 발현 플랫폼에 대한 호주 특허 등록으로 기술 독점력 강화 및 미래 성장 기대감 증가.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 11,800Won52-week high 32,00052-week low 11,800

1-month return0.0Point

1m -25.83% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

7 totalPositive 0Neutral 7Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-22
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-22
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-22
Neutral자기주식처분결과보고서2026-05-22
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-22